These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 22035911)

  • 1. [The neutrophil gelatinase-associated lipocalin, or LCN 2, marker of aggressiveness in clear cell renal cell carcinoma].
    Perrin C; Patard JJ; Jouan F; Collet N; Théoleyre S; Edeline J; Zerrouki S; Laguerre B; Bellaud-Roturaud MA; Rioux-Leclercq N; Vigneau C
    Prog Urol; 2011 Nov; 21(12):851-8. PubMed ID: 22035911
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A case-control study of pre-operative levels of serum neutrophil gelatinase-associated lipocalin and other potential inflammatory markers in colorectal cancer.
    Duvillard L; Ortega-Deballon P; Bourredjem A; Scherrer ML; Mantion G; Delhorme JB; Deguelte-Lardière S; Petit JM; Bonithon-Kopp C;
    BMC Cancer; 2014 Dec; 14():912. PubMed ID: 25472811
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neutrophil gelatinase-associated lipocalin (NGAL) and matrix metalloproteinase-9 (MMP-9) prognostic value in stage I colorectal carcinoma.
    Barresi V; Reggiani-Bonetti L; Di Gregorio C; Vitarelli E; Ponz De Leon M; Barresi G
    Pathol Res Pract; 2011 Aug; 207(8):479-86. PubMed ID: 21726963
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serum Neutrophil Gelatinase B-associated Lipocalin and Matrix Metalloproteinase-9 Complex as a Surrogate Marker for Mucosal Healing in Patients with Crohn's Disease.
    de Bruyn M; Arijs I; De Hertogh G; Ferrante M; Van Assche G; Rutgeerts P; Vermeire S; Opdenakker G
    J Crohns Colitis; 2015 Dec; 9(12):1079-87. PubMed ID: 26351381
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Significant elevation and correlation of plasma neutrophil gelatinase associated lipocalin and its complex with matrix metalloproteinase-9 in patients with pelvic inflammatory disease.
    Tsai HT; Su PH; Lee TH; Tee YT; Lin LY; Yang SF; Wang PH
    Clin Chim Acta; 2011 Jun; 412(13-14):1252-6. PubMed ID: 21439274
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Maternal serum levels of neutrophil gelatinase-associated lipocalin (NGAL), matrix metalloproteinase-9 (MMP-9) and their complex MMP-9/NGAL in pregnancies with preeclampsia and those with a small for gestational age neonate: a longitudinal study.
    Karampas G; Eleftheriades M; Panoulis K; Rizou M; Haliassos A; Hassiakos D; Vitoratos N; Rizos D
    Prenat Diagn; 2014 Aug; 34(8):726-33. PubMed ID: 24550181
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diagnostic and prognostic value of neutrophil gelatinase-associated lipocalin, matrix metalloproteinase-9, and tissue inhibitor of matrix metalloproteinases-1 for sepsis in the Emergency Department: an observational study.
    Wang M; Zhang Q; Zhao X; Dong G; Li C
    Crit Care; 2014 Nov; 18(6):634. PubMed ID: 25407832
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diagnostic and prognostic significance of neutrophil gelatinase-associated lipocalin in disseminated intravascular coagulation.
    In JW; Kim JE; Jeong JS; Song SH; Kim HK
    Clin Chim Acta; 2014 Mar; 430():145-9. PubMed ID: 24508993
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Clinical significance of the detection of serum neutrophil gelatinase-associated lipocalin in human colorectal cancer].
    Ding L; Zhang X; Zhang Y; Yang G; Liao X; Shen Z; Qiu J; Mao W; Hu L; Shao S; Shang S
    Zhonghua Wei Chang Wai Ke Za Zhi; 2014 Jun; 17(6):589-93. PubMed ID: 24953369
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serum concentrations of atherogenic proteins neutrophil gelatinase-associated lipocalin and its complex with matrix metalloproteinase-9 are significantly lower in women with polycystic ovary syndrome: hint of a protective mechanism?
    Diamanti-Kandarakis E; Livadas S; Kandarakis SA; Margeli A; Papassotiriou I
    Eur J Endocrinol; 2008 Apr; 158(4):525-31. PubMed ID: 18362300
    [TBL] [Abstract][Full Text] [Related]  

  • 11. NGAL and NGALR overexpression in human hepatocellular carcinoma toward a molecular prognostic classification.
    Zhang Y; Fan Y; Mei Z
    Cancer Epidemiol; 2012 Oct; 36(5):e294-9. PubMed ID: 22728279
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diagnostic value of neutrophil gelatinase-associated lipocalin/matrix metalloproteinase-9 pathway in transitional cell carcinoma of the bladder.
    Candido S; Di Maso M; Serraino D; McCubrey JA; Bortolus R; Zanin M; Battiston M; Salemi R; Libra M; Polesel J
    Tumour Biol; 2016 Jul; 37(7):9855-63. PubMed ID: 26810191
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Stromal expression of neutrophil gelatinase-associated lipocalin correlates with poor differentiation and adverse prognosis in oral squamous cell carcinoma.
    Shinriki S; Jono H; Ueda M; Obayashi K; Nakamura T; Ota K; Ota T; Sueyoshi T; Guo J; Hayashi M; Hiraki A; Nakayama H; Yamashita S; Shinohara M; Ando Y
    Histopathology; 2014 Feb; 64(3):356-64. PubMed ID: 24118080
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Circulating osteoglycin and NGAL/MMP9 complex concentrations predict 1-year major adverse cardiovascular events after coronary angiography.
    Cheng JM; Akkerhuis KM; Meilhac O; Oemrawsingh RM; Garcia-Garcia HM; van Geuns RJ; Piquer D; Merle D; du Paty E; Galéa P; Jaisser F; Rossignol P; Serruys PW; Boersma E; Fareh J; Kardys I
    Arterioscler Thromb Vasc Biol; 2014 May; 34(5):1078-84. PubMed ID: 24651681
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic value of plasma neutrophil gelatinase-associated lipocalin for mortality in patients with heart failure.
    van Deursen VM; Damman K; Voors AA; van der Wal MH; Jaarsma T; van Veldhuisen DJ; Hillege HL
    Circ Heart Fail; 2014 Jan; 7(1):35-42. PubMed ID: 24347663
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neutrophil gelatinase-associated lipocalin (NGAL) and matrix metalloproteinase-9 (MMP-9) prognostic value in lung adenocarcinoma.
    Ruiz-Morales JM; Dorantes-Heredia R; Arrieta O; Chávez-Tapia NC; Motola-Kuba D
    Tumour Biol; 2015 May; 36(5):3601-10. PubMed ID: 25542236
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Circulating levels of matrix metalloproteinase-9 (MMP-9), neutrophil gelatinase-associated lipocalin (NGAL) and their complex MMP-9/NGAL in breast cancer disease.
    Provatopoulou X; Gounaris A; Kalogera E; Zagouri F; Flessas I; Goussetis E; Nonni A; Papassotiriou I; Zografos G
    BMC Cancer; 2009 Nov; 9():390. PubMed ID: 19889214
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serum neutrophil gelatinase-associated lipocalin (NGAL) in patients with Shiga toxin mediated haemolytic uraemic syndrome (STEC-HUS).
    Lukasz A; Beneke J; Menne J; Vetter F; Schmidt BM; Schiffer M; Haller H; Kümpers P; Kielstein JT
    Thromb Haemost; 2014 Feb; 111(2):365-72. PubMed ID: 24172823
    [TBL] [Abstract][Full Text] [Related]  

  • 19. ARCHITECT® urine-neutrophil gelatinase-associated lipocalin (u-NGAL) assay as new prognostic marker for clear cell Renal Cell Carcinoma (ccRCC) (preliminary results).
    Ben Khadhra H; Rose-Robert F; Herpe YE; Sevestre H; Choukroun G; Catherine L; Amant C; Saint F
    Int Urol Nephrol; 2021 Jan; 53(1):59-67. PubMed ID: 32783115
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic utility of neutrophil gelatinase-associated lipocalin in predicting mortality and cardiovascular events in patients with ST-segment elevation myocardial infarction treated with primary percutaneous coronary intervention.
    Lindberg S; Pedersen SH; Mogelvang R; Jensen JS; Flyvbjerg A; Galatius S; Magnusson NE
    J Am Coll Cardiol; 2012 Jul; 60(4):339-45. PubMed ID: 22813613
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.